The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

Adrenal Metastasis from Renal Cell Carcinoma Regressed with Allergen-removed Rhus verniciflua Stokes;A Case Report

알러젠 제거 옻나무 추출물 투여로 소퇴된 신세포암 유래 부신전이암 1례

  • Jeong, Ui-Min (Oriental Internal Medicine, Kyunghee University Neo Medical Center) ;
  • Jeong, Jong-Soo (Oriental Internal Medicine, Kyunghee University Neo Medical Center) ;
  • Jung, Hyun-Sik (Oriental Internal Medicine, Kyunghee University Neo Medical Center) ;
  • Park, Jae-Woo (3rd Dept. of Internal Medicine, College of Oritental Medicine, Kyung-hee University) ;
  • Yoon, Seong-Woo (Oriental Internal Medicine, Kyunghee University Neo Medical Center, 3rd Dept. of Internal Medicine, College of Oritental Medicine, Kyung-hee University)
  • 정의민 (경희대학교 동서신의학병원 한방내과) ;
  • 정종수 (경희대학교 동서신의학병원 한방내과) ;
  • 정현식 (경희대학교 동서신의학병원 한방내과) ;
  • 박재우 (경희대학교 한의과대학 비계내과학교실) ;
  • 윤성우 (경희대학교 동서신의학병원 한방내과, 한의과대학 비계내과학교실)
  • Published : 2008.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Renal cell carcinoma(RCC) is one of the major malignant renal cell tumors. Although RCC can metastasize to almost every organ, the most common metastatic sites are the lung parenchyma, the bones, the liver, and the brain. Adrenal metastasis from RCC is extremely rare. Adrenal metastasis from RCC shows poor prognosis, with little benefit from chemotherapy, radiation therapy, hormone therapy or immunotherapy. In this report, we describe a case of an RCC patient who showed lung and adrenal metastasis. The patient underwent left nephrectomy and chemotherapy(sunitinib), which were not effective. He refused further conventional medical treatment, and instead started treatment with Traditional Korean Medicine using allergen-removed Rhus verniciflua Stokes. After about 3 months of this treatment, the size of the adrenal tumor had decreased significantly with good performance status. Further study will be needed to demonstrate the tumor regression effect of allergen-removed Rhus verniciflua Stokes on patients with metastatic renal cell carcinoma.

Keywords